Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study
Status:
Completed
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
The proposed pilot study will estimate the efficacy and safety of a novel therapeutic agent,
cabergoline, with a clinical standard therapy, norethindrone acetate, for the treatment of
endometriosis-associated pain in young women with endometriosis.
Phase:
Phase 2
Details
Lead Sponsor:
Boston Children's Hospital Boston Children’s Hospital